Kit for identifying brucella abortus and other brucella species
A technology for Brucella bovis and Brucella species is applied in the field of kits for identifying Brucella bovis and other species of Brucella, which can solve the problem of interfering with the purification work of herds and inability to distinguish immunized animals. Natural virulent strains of infection antibodies and other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Cloning, prokaryotic expression of embodiment 1 Brucella bovis deletion gene NC_017250 and Brucella BP26 gene
[0048] Through the whole genome sequencing of the A19 vaccine strain, the predicted coding gene was compared with the published Brucella genome data to find out the missing gene of the bovine species compared with other non-bovine species of Brucella, and use the PCR method from S2 The deletion gene NC_017250 (SEQ ID NO.1) was amplified in the genome, and the Brucella BP26 gene (SEQ ID NO.3) was used as a control gene. After cloning and sequencing, it was constructed into the prokaryotic expression vector pET30 and transformed into E .coli BL21(DE3) was induced to express, and the immunogenicity of the two recombinant proteins NC_017250 and BP26 was verified by western-blotting method.
[0049] 1. Experimental method:
[0050] 1.1 Primer design
[0051] According to the NC_017250 and BP26 gene sequences, primers were designed with Oligo6.0, and EcoRI and Xho...
Embodiment 2
[0118] Example 2 Establishment of iELISA method for identifying bovine and non-bovine Brucella antibodies in domestic animals
[0119] 1. Experimental method
[0120] 1.1 Determination of the optimal coating concentration of antigen and the optimal dilution of serum
[0121] According to the checkerboard titration method, the two recombinant proteins purified in Example 1 were diluted with the coating solution. The initial antigen concentration of NC_017250 was 0.5 μg / μL, and the dilution gradient was 1:6.25, 1:12.5, 1:25, 1 : 50 four gradients; BP26 initial antigen concentration 0.553μg / μL dilution gradient is 1:25, 1:50, 1:100, 1:200 four gradients, add 100μL to each well, coat at 4°C overnight, the next day Discard the liquid in the well, wash it three times with washing solution, let it stand for 5 minutes each time, and pat dry the liquid in the well of the microplate after washing. Add 100 μL of blocking solution to each well, place at 37°C for 2 hours, wash with washi...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com